September 24, 2024 11:45 ET | Source: Transgene S.A. Transgene S.A.
2024 Half Year Financial Report
Attachment
Transgene Further Strengthens Scientific Advisory Board with Appointments of Renowned Cancer Immunotherapy Experts Antoine Italiano and Ignacio Melero
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2025
